CEL SCI CORP (CVM) Stock Profile — Insider Trades & Financials

Net Income-$5.5M

EPS$-0.68

Market Cap$36.3M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Geert Kersten

CEO & Executive Director

Cel-Sci Corporation, is a biotechnology company that tests drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of immunotherapy products.

Founded: 1983
Employees: 44
Headquarters: VIENNA, VA, United States
Website: cel-sci.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-49.10%

ROA?

-23.89%

D/E Ratio?

1.06

📊

Profitability Ratios

Current Ratio?

1.39

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Jun 8, 2026 (in 62 days)

Quarterly Report (10-Q) — Based on filing pattern

Jun 8, 2026

Predicted10-Q

Feb 17, 2026

10-QQ1 20268d after period end

Dec 29, 2025

10-KQ4 202510d after period end

Dec 29, 2025

10-KFY 202590d after period end

Aug 14, 2025

10-QQ3 20251d after period end

May 14, 2025

10-QQ2 20255d after period end

Feb 14, 2025

10-QQ1 20254d after period end

Jan 13, 2025

10-KQ4 20247d after period end

Jan 13, 2025

10-KFY 2025105d after period end

Loading company sections...

CEL SCI CORP

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness